IRCCS San Camillo
Venezia, Italy, 30126
Location status: Recruiting
NCT Number: NCT07549724
This study aims to translate and validate Italian versions of several clinical assessment tools for patients with neurogenic dysphagia. The instruments include:
The New Zealand Secretion Severity Scale, which evaluates secretion management; The Reflex Cough Test from the I&I cranial nerves assessment; The VASES scale used during fiberoptic endoscopic evaluation of swallowing; The Drooling Severity Scale, which measures saliva control.
The study will include approximately 100 patients with neurogenic dysphagia. The goal is to provide reliable, standardized tools in Italian to support clinicians in assessing swallowing and oral-motor function in patients with neurological disorders.
Interested in participating?
Request Info18 year–85 year
All sexes
Observational
Venezia, Italy, 30126
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
IInclusion Criteria:
Adult patients (≥18 years) diagnosed with neurogenic dysphagia due to any neurological condition (e.g., stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury) Able to understand and comply with study procedures Provide written informed consent (or legal representative consent if necessary) Stable medical and neurological condition at the time of assessment
Exclusion criteria
Active respiratory infection or acute illness affecting swallowing at the time of assessment History of head and neck surgery or anatomical abnormalities preventing standardized assessment of swallowing or reflex cough Severe uncontrolled comorbidities (cardiac, pulmonary, or systemic) that make study participation unsafe
no intervention but validation of assessments
Time frame: Baseline
Description: Internal consistency of the New Zealand Secretions Severity Scale (NZSS) and Drooling Severity Scale (DSS).
Scale titles:
New Zealand Secretions Severity Scale (NZSS) Drooling Severity Scale (DSS)
Range:
NZSS: 0-7 (higher score = greater secretion severity) DSS: 1-5 (higher score = greater drooling severity) Metric: Cronbach's alpha (0-1; higher = better consistency)
Time frame: baseline
Inter-rater reliability of secretion, drooling, and swallowing assessment scales
Scale titles:
New Zealand Secretions Severity Scale (NZSS) Drooling Severity Scale (DSS) Visual Analysis of Swallowing efficiency and safety (VASES)
Range:
NZSS: 0-7 (higher = worse secretion severity) DSS: 1-5 (higher = worse drooling severity) VASES: - pharyngeal residue: 0-4 (higher = worse residue severity); PAS: 1-8 (higher = worse airway invasion severity) Metric: Intraclass Correlation Coefficient (ICC, 0-1; higher = better reliability)
Time frame: Time Frame: Baseline and 7 days
Test-retest reliability of clinical swallowing and secretion measures
Scale titles:
New Zealand Secretions Severity Scale (NZSS) Drooling Severity Scale (DSS) Reflex Cough Test
Range:
NZSS: 0-7 DSS: 1-5 Reflex Cough Test: 0-4 (based on increasing citric acid concentrations 0.1-0.4; higher = worse cough reflex sensitivity impairment) Metric: Intraclass Correlation Coefficient (ICC, 0-1; higher = better reliability)
Time frame: Time Frame: Baseline
Construct validity of secretion and drooling scales during FEES
Scale titles:
New Zealand Secretions Severity Scale (NZSS) Drooling Severity Scale (DSS) VASES (Visual Analysis of Swallowing Efficiency and Safety)
Range:
NZSS: 0-7 DSS: 1-5 VASES: pharyngeal residue: 0-4 (higher = worse residue severity); PAS: 1-8 (higher = worse airway invasion severity) Metric: Correlation coefficients (-1 to +1; absolute value closer to 1 = stronger association)
Contact information is provided by the study sponsor or research team.
IRCCS San Camillo, Venezia, Italy
Other
Acronym: Val_Dysphagia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07027826
Deglutition Disorders, Digestive System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06638944
Basal Ganglia Diseases, Brain Diseases
Champaign, Illinois, United States
View Trial DetailsNCT06070376
Deglutition Disorders, Digestive System Diseases
São Paulo, Brazil
View Trial DetailsNCT06866418
Deglutition Disorders, Digestive System Diseases
Phoenix, Arizona, United States
View Trial Details